Research Summaries

risk management
risk management
08/15/2022
In this COVID-19 roundup, coverage includes the addition of an Omicron variant component to future vaccine boosters, the relationship between a COVID-19 infection and damage to heart muscle, and how...
08/15/2022
Vaccination
Vaccination
07/15/2022
Coverage includes a recent update to the emergency use authorization for Paxlovid, rates of maternal morbidity during the pandemic, the impact of maternal vaccination in outcomes of infants, and the...
07/15/2022
Pregnancy
Pregnancy
06/30/2022
For their literature review, the researchers included studies conducted before and during the COVID-19 pandemic and evaluated the management strategies for ectopic pregnancies during those periods.
06/30/2022
immunology
immunology
06/22/2022
This COVID-19 roundup includes coverage of the FDA’s latest emergency use authorization for vaccination in new pediatric populations, the risk of myocarditis following hospitalization, and the duration of...
06/22/2022
mortality
mortality
05/23/2022
This week’s COVID-19 roundup coverage includes national trends in mortality due to alcohol use disorder during the pandemic, as well as the impact of hormone replacement therapy on COVID-19 mortality and...
05/23/2022
management
management
05/18/2022
In this COVID-19 roundup, we discuss the expansion of eligible populations for a COVID-19 booster dose, approval of a nonprescription respiratory infection test, thrombosis risk after COVID-19 infections,...
05/18/2022
Symptoms
Symptoms
05/09/2022
In this COVID-19 roundup, we discuss the recent limitation for the use of the Janssen COVID-19 vaccine, the seroprevalence of asymptomatic infection, neurologic symptoms associated with COVID-19, and...
05/09/2022
treatment
treatment
05/02/2022
In this week’s COVID-19 roundup, coverage includes the pandemic’s impact on antimicrobial resistance, the persistence of COVID-19 symptoms following infection, a potential treatment for respiratory viruses,...
05/02/2022
treatment
treatment
04/26/2022
The US Food and Drug Administration has approved the first COVID-19 treatment for use in pediatric patients aged 12 years and younger.
04/26/2022
management
management
04/25/2022
In this week’s COVID-19 roundup, we discuss the EUA for a breathalyzer test, updated WHO guidelines, drug-drug interactions when treating COVID, and psychiatric disorders after breakthrough infection.
04/25/2022